I can see a takeover attempt occurring H2 2014 and this would be for the protein division alone (PPPS and bioseparation). Based on revenue generation capacity of the Laval plant, the Isle of Mann plant, future royalties and huge growth potential, a price of $3+ is possible. Once the protein division is split off, I can see a major dividend being paid and efforts focussed on the therapeutic division. If 4050 and other therapeutic compounds live up to their potential, the value of the therapeutic division could easily exceed that of the protein division. We will get a better feel for this once the first round of clinical studies is completed, probably in early 2014. The future is incredibly bright for PLI and its shareholders. Sit tight and enjoy the ride!